1st Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for MODERNA US INC.
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain
Foreign entity interest: Moderna (China) Biotech Ltd has an interest in vaccine technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
| MARC LAMPKIN | — |
| DEEMA TARAZI | — |
| JONATHAN TOWERS | — |
| ANDREW USYK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.